Did not make myself clear. Was more concerned that BD would possibly infringe on Unilife's Patents, a legal fight causing much greater disruption to Unilife than themselves.
But your point about SA being an effective partner to Unilife and one of BD's biggest customers is a great one. If BD play unfair towards Unilfe they will annoy their biggest customer.
Only thing BD can do (except a takeover) is fight fair and try to invent a product as good as Unilife's. And that is the big unknown. They have a massive R&D so its more of a question when (not if) they will achieve a product as good.
If they were to bring a product to market within the next two to three years that was as good as Unilife's, this would greatly reduce Unilife's potential. If they cannot, Unilife could well be selling a Billion Syringes by 2016. And we will be sitting on huge profits (10 times + by my calcs).
Either way I think Unilife has a great margin of saftey. With the backing of SA and the operational obstacles behind them we are set for a big sp re-rating when contracts and pricing of product become a reality over the next 12 months.
I have one question that I would love to hear posters feedback from. What are the odds BD or another competitor will come up with a product as good as Unilife's within the following periods: - 1 year - 2-3 years - 5 years
cheers.
UNS Price at posting:
$1.04 Sentiment: LT Buy Disclosure: Held